DatasetName,EPS8_S(289) EPS8_S(298) EPS8_S(3) EPS8_S(476) EPS8_S(478) EPS8_S(55) EPS8_S(57) EPS8_S(58) EPS8_S(63) EPS8_S(642) EPS8_S(656) EPS8_S(659) EPS8_S(661) EPS8_S(662) EPS8_S(664) EPS8_S(667) EPS8_S(672) EPS8_S(676) EPS8_S(677) EPS8_S(679) EPS8_S(685) EPS8_S(693) EPS8_S(702) EPS8_S(787) EPS8_S(811) EPS8_S(815) EPS8_S(823) EPS8_S(828) EPS8_S(832) EPS8_T(214) EPS8_T(223) EPS8_T(240) EPS8_T(242) EPS8_T(317) EPS8_T(605) EPS8_T(629) EPS8_T(699) EPS8_Y(525),EPS8_S(669) EPS8_T(597) EPS8_Y(774),EPS8_S(241) EPS8_S(625) EPS8_S(663) EPS8_S(666) EPS8_T(657) EPS8_Y(597) EPS8_Y(602)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,0.4724104872235377,,
FSO2013_Ratio M/L normalized Rep3,0.4859072915988605,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,0.47578572141959574,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,0.473719211868597,,
HS2024_6_B_T3,0.4761065806880424,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,0.47968366025128634,,
SR2019_MDAMB231_Biol_repl_4,0.4803380768298878,,
GF2025_P2_Sph,0.4772274364694142,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,0.6802167136132536
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,0.48485486301425706,,
FSO2013_Ratio M/L normalized Rep1___1,0.4791144515046572,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,0.4794727197849092,,
RB2022_5_PreEndurance,0.47756039252185584,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.498339732537646,,0.6646138507295849
WZ2023_Pu_010_30min,0.46935363981289874,,0.68166056181373
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,0.48258991519418626,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.47786280151400223,,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.4752823409562581,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,0.4777867048812935,,
RB2022_5_PreSprint,0.48077880923022276,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,0.4876197741155722,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,0.476221533128292,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.48947287464639383,,0.7124941456213072
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,0.4771625856832824,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,0.4826570389247296,,
GF2025_P6_Sph,0.4809775498724279,,
RB2022_2_PreSprint,0.48005368224435996,,
ZX2022_CB treated Replicate 3,0.472982553640131,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.462873914857948,,0.6847551145711501
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,,,
WZ2023_Pu_005_10min,0.46650260984799125,,0.6827096610949964
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.48068426154652716,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.4765929801951792,,0.6836843305333311
AH2018_SILAC_MR_2_X,0.4769760059065175,,
HS2024_4_PD_T2,0.47551062254375287,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,0.4775344247180088,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,0.4769425997018328,,
EJN2021_3_Rest_Basal,0.4797457857206913,,
CR2017_Ratio Replicate 1.3,0.4790151751466977,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,0.47930992086201263,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,,
HS2024_7_PD_T2,0.4791683397584283,,
FSO2013_Ratio H/L normalized Rep1___1,0.48277106883701487,,
AH2018_LFQ_1_C,0.4801283492160451,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,,
HS2024_3_B_N1,0.48591312897501615,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.47191958978061466,,0.6851746079925926
CK2022_11 40-1,0.48081758755053805,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,0.47162404810026787,,
FSO2013_Ratio H/L normalized Rep2,0.47445671212336077,,
WZ2023_Pu_005_20min,0.47454479302636104,,0.6809263952805716
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,0.47762152709724204,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.47785683151196967,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,0.4853839776180158,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,0.48222320314876194,,
FSO2013_Ratio M/L normalized Rep3___2,0.490299976246694,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,0.47589793572337247,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,
CK2022_1 200-1,,,
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,0.4785526899567387,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,0.47972736567420293,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,0.48626197432721313,,
EP2017_Mitotic R#2 normalized log2 ratio,0.4856860339938514,,0.6653840875051183
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.4785243961756202,,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.473374528588811,,
KBE2022_Log2_Ex_8_T,,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,0.4778765442705576,,
RN2012_L11,0.4843015547899654,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,0.47514965669188913,,
AH2018_LFQ_M_2_C,0.4762377813469649,,
CK2022_3 40-1,0.4807500636788136,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,0.47575368909592247,,
YA2020_Reporter_intensity_Cancer_No.5,0.4750690513265729,,
HH2022_Reporter intensity 8,0.48177631162112466,,0.6731756713578054
ZQ2022_N2,0.48609121695780355,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,0.48632012901808214,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.48593379660694663,,
EJN2021_5_Rest_Basal,0.48092350186199195,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,0.4922045617459819,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,0.696069554753307
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,0.47980836354214484,,
YA2020_Reporter_intensity_Normal_No.1,0.477714143828974,,
HS2024_3_B_T1,0.48766220323594456,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,0.48514502207535076,,
CR2017_Ratio Replicate 3,0.4803578797078106,,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,0.4834793087182677,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.47933998020635404,,
HS2024_8_I_T3,0.47919217143721266,,
CF2017_EOC 3,0.4729363503754438,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,0.48598095767012345,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.47121943959473217,,0.681156039733722
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.48064264264036116,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,,
KS2014_Intensity N3,0.4757857002746357,,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,0.47629584075866555,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,0.4778018329278637,,
FSO2013_Ratio H/M normalized Rep2,0.48986370553444014,,
RAM2015_Log2 A,0.47854603542698837,,
HS2024_8_PD_T1,0.4779562720116566,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,0.4802402079842654,,
KS2014_Intensity E15_2,0.47696565212108955,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,0.4735945700824178,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,0.47578342635463605,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,0.47321014258812283,,
AH2018_SILAC_M_3_X,0.4794361560723809,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.49817810684563923,,0.6644379543869041
HS2024_6_B_N1,0.4807669432711734,,
KBE2022_Log2_Ex_27_T,,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.4797942928304848,,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.4792724481433659,,
AH2018_SILAC_IT_3_X,0.4852302304307722,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,0.48418402173560476,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,,0.6729933682018042
SR2019_HCC1954_Biol_repl_2,0.4765684054462385,,
CK2022_14 40-1,0.4802576853048201,,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,0.47518233739101207,,
DL2023_control-1,,,
AR2021_ALG 10 μM,0.48849852766838625,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.4833034021909548,,
EJN2021_4_Rest_Ins,0.4811159341683621,,
RN2012_H05,0.4848464185679228,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.4903088491706257,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,0.47924447060717396,,
EJN2021_1_Rest_Ins,0.4820068343175518,,
HH2022_Reporter intensity 3,0.4748224964702543,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,0.480118869063977,,0.6710487968679131
AH2018_SILAC_IT_1_C,0.47568124741877515,,
JW2021_After_3,,,
GF2025_P8_Sph,0.4807309017062075,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,0.47883852872757937,,0.6709090239596086
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,,
CK2022_11 200-1,,,
CK2022_12 200-1,,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,0.48214189686863923,,0.6881350058049913
WZ2023_Su_010_20min,0.4762087430510522,,0.681363333808682
AH2018_TMTMS2_2_N,0.4741205767389016,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.4794722918448264,,
AH2018_TMTMS3_Pool,0.48741831482778825,,
KS2014_Intensity N4,0.4696694119424977,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,0.47803005558667533,,
CK2022_14 200-1,,,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,0.47754392422401837,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.4868445793426581,,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.47951209699053843,,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,
GF2025_P1_Adh,0.48045760063764115,,
GF2025_P1_Sph,0.48112777323246536,,
EJN2021_5_Ex_Basal,0.4806247097084772,,
HS2024_7_I_T3,0.47929932190528224,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.46067322926702453,,0.6834762920744677
CF2017_EOC 1,0.4654062871984766,,
CK2022_3 200-1,,,
AH2018_LFQ_IT_3_C,,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,0.4816394656261443,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,0.4804805512442478,,0.6818431132332615
HS2024_6_PD_T2,0.4829147506913923,,
HS2024_5_B_T1,0.4726144287178523,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,0.48087568241025247,,
HS2024_3_B_T2,0.4822516011890149,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,0.48090232781057934,,
RB2022_1_PostSprint,0.4791181560433431,,
CK2022_4 200-1,,,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,
AR2021_ALG 1 μM,0.4744358341337951,,
HS2024_4_B_T1,0.472784352634139,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,0.4791607643864909,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.4782834580192796,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,0.6833460106663817
GF2025_P7_Adh,0.47884882367521975,,
CK2022_9 16-1,,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,0.4770843760606072,,
CK2022_13 200-1,,,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,,,
FS2019_db/db3,,,
CK2022_15 40-1,0.4804195008856255,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.4766958348625874,,0.6830590948062711
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,,
HS2024_5_PD_T3,0.47524764050361307,,
AH2018_TMTMS3_3_X,0.4876642242177843,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,0.48541812406702034,,0.6764478428940814
KBE2022_Log2_Ex_40_U,,,
AH2018_LFQ_M_1_N,0.4798866485006044,,
KBE2022_Log2_Ex_27_U,,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,0.4782987177173943,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,0.475105883407993,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,0.47594644896877164,,
YA2020_Reporter_intensity_Normal_No.4,0.4767679529303419,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,
RN2012_L13,0.4720988884368864,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,0.4801253039194511,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,0.48154439482943817,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,0.487892648776056,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.48067441548847856,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,,
HH2022_Reporter intensity 6,0.48251405459114866,,0.6782820419462418
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,0.4758620228840728,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,0.4770528091910128,,
GF2025_P3_Adh,0.48261866266309106,,
SR2019_JIMT1_Biol_repl_2,0.4783641860118661,,
AH2018_TMTMS2_1_C,0.4754977177858606,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,,
KBE2022_Log2_Ex_19_U,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,0.4827325019775537,,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,0.4753448975212933,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,0.4777997532963353,,
RB2022_5_RecoverySprint,0.4830293182735998,,
RB2022_7_RecoverySprint,0.48533823854259783,,
YA2020_Reporter_intensity_Normal_No.3,0.4779737787458122,,
HS2024_8_B_T2,0.4750746210284382,,
AH2018_LFQ_1_X,0.4802762798799769,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,0.47255318693413567,,
HH2022_Reporter intensity 1,0.4751447841006371,,
HH2022_Reporter intensity 2,0.4754235608199712,,0.6956860817688073
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,0.481006503353236,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,0.4729168962795068,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,0.4811072730684875,,
HS2024_8_B_T1,0.481343653745655,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.4824054843646281,,0.6737550568419227
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,0.4766815424601391,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,0.46645944401754913,,
AR2021_KD 72h,0.47671314026288863,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.48588462815292077,,
KBE2022_Log2_Ex_9_U,,,
AH2018_SILAC_M_3_N,0.47991636345538413,,
KBE2022_Log2_Ex_13_T,,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,0.4765506455755658,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,0.4763656897422613,,
PG2020_Intensity 10h_A,,,
RN2012_L12,0.47662998786148575,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,0.4796319735089993,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,0.5004652324403496,,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.48011498717802886,,
RB2022_7_RecoveryEndurance,0.4799100736360407,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.4812802974000613,,
TM2022_S2.12h.B,,,
RN2012_L15,0.4797191997560151,,
KS2014_Intensity pY_PV3,0.4821446462909923,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,0.4911810260684367,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,0.4811930395134249,,
RB2022_1_PreSprint,0.4798347098738392,,
HS2024_4_I_N1,0.48377304898158013,,
CK2022_7 200-1,,,
CK2022_5 200-1,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,0.4745781906724515,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,0.48876233338000097,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,,
AH2018_SILAC_3_C,0.47963407979508343,,
EJN2021_5_Rest_Ins,0.48023201213361016,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,0.5038910191406785,,
CK2022_4 16-1,,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,0.48077199356970146,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,0.47851373920473206,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,0.4714852350961892,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,0.48493149228514676,,
KBE2022_Log2_Ex_9_T,,,
AH2018_SILAC_IT_2_N,0.48288469971433123,,
AH2018_SILAC_IT_1_X,0.4851732123494658,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,0.4808669377765145,,
UK2020_UA_2,0.4764325119374858,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.48561964283548,,
WZ2023_Pe_025_20min,0.4670179693374494,,0.6845239935262529
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,0.48040673674429124,,
HS2024_4_I_N2,0.4741668529183202,,
AH2018_TMTMS2_3_N,0.4772622903630525,,
RN2012_H06,0.48068537826379787,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,0.4763784654219558,,
WZ2023_Su_005_30min,0.4791170952708115,,0.6851432757896906
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,0.4785241346510768,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,0.4752893517607472,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.48062566787446453,,
WZ2023_Su_025_10min,0.4687605240458134,,0.6844696186975909
AH2018_LFQ_IT_4_X,0.47930632452461575,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,0.4817588658781833,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.4784041553280527,,0.6830916635829901
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,0.4781807111557958,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,0.6899911590319683
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.49177486513134167,,0.716131515685373
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,0.4781707244848139,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,,,
EP2017_Untreated R#1 normalized log2 ratio,0.48119964752502986,,0.661206088054593
RN2012_L10,0.4806606790001688,,
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,0.4859154524562208,,0.6571493306811028
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,0.48520170430359033,,
HS2024_4_B_T3,0.47556308792116314,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,0.4863171673622122,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,0.4769471102908074,,
KBE2022_Log2_Ex_6_U,,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.48071163547149015,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,,,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.48192711638246644,,0.6707756034798465
GF2025_P9_Sph,0.47711835410217857,,
CK2022_6 200-1,,,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.4846844650357991,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,0.47813869590559316,,
HS2024_4_I_T2,0.47646488035517637,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,0.47676874070598957,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,0.4823809989666314,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,0.48066213792295515,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,0.474669488369758,,0.6851171525711802
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,,,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,,
RB2022_7_PostEndurance,0.47730666666962523,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.48537758175934126,,0.7152698123295362
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,0.4793282491278703,,
KBE2022_Log2_Ex_29_T,,,
HS2024_7_I_T2,0.4805702002924345,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,0.4714224618465362,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.48094722361776615,,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,0.48178425713157713,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,0.4777676144359531,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,0.482287796386597,,
KBE2022_Log2_Ex_39_U,,,
EP2017_Untreated R#3 log2 ratio,0.4745270532659111,,0.6849849973925384
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,,
HS2024_8_PD_T2,0.47530244916907366,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,0.4830018410230284,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,0.47908943656616504,,
CR2017_Ratio Replicate 2.3,0.47789300379688626,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.4876817125101605,,
YA2020_Reporter_intensity_Normal_No.2,0.4763728039508959,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,0.47672031189109015,,
HS2024_3_PD_T3,0.47471604485330504,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,0.477126132733899,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,,
CK2022_2 16-1,,,
RAM2015_Log2 B,,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,0.47927722471748535,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.48102168369923587,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,0.4741137826004071,,
UK2020_HCM_5,0.47642467752586054,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,0.4808385033824029,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,0.47577909391976003,,0.6809976761385831
AH2018_LFQ_4_N,0.4784434154110599,,
CR2017_Ratio Replicate 1.2,0.47879788399415746,,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,0.4854466272628691,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,0.4836312231427852,,0.6783568107739301
AH2018_SILAC_M_1_X,0.4780270702311478,,
RB2022_7_PreEndurance,0.4835522095677558,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.47872981346202187,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,0.6818074282209036
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,0.47646083881593376,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.48716307010685095,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,0.47950525421104034,,
KS2014_Intensity C5,0.47218744993013134,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,0.47903410899131904,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.47968225223268357,,
RB2022_3_PostStrength,0.47761429971027036,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,0.4864096171224412,,0.6953731142345119
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,0.47546428232097987,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,0.48052380949827567,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,0.48045319872233067,,
KS2014_Intensity E15_3,0.4775511940508515,,
GF2025_P3_Sph,0.4802549851004124,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,0.475772954071886,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,0.4952094152957683,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.4785985863585088,,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.4831967539120001,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,,
ZQ2022_N1,0.4844138367205573,,
LY2019_P6-,,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,0.4765002258289312,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.4806710104856295,,
AH2018_LFQ_3_N,0.48028445003469106,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,0.4770115467809586,,
KBE2022_Log2_Ex_13_U,,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,0.48353576819697197,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.47995483305886333,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,0.48013906584059984,,
HS2024_5_PD_T2,0.47510408305529994,,
WZ2023_Su_025_20min,0.47452857456455505,,0.6841439298808537
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,0.481027273952289,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.4802361084964332,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,0.4789542066798784,,
RN2012_H02,0.4835742975158909,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,0.4788296831893641,,
HS2024_3_B_N2,0.47243989053497143,,
EJN2021_4_Ex_Ins,0.48068469577355866,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,0.4825147777175181,,
EP2017_Pervanadate R#3 log2 ratio,0.4900504759279996,,0.7133508360168032
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,0.4817983970261355,,
AH2018_LFQ_M_4_C,0.47810795697519576,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,0.4844741422069411,,
CK2022_6 40-1,0.4802380149040539,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,,
LY2019_P3-,,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,0.48063398792771844,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.46838764767431035,,0.6813349239599032
HS2024_8_PD_T3,0.4768554629716786,,
EJN2021_3_Ex_Basal,0.4806069915816679,,
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.4731758923636348,,0.6817665810988717
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.48119686122465954,,
RB2022_1_RecoveryStrength,0.4801341968300142,,
SR2019_HCC1954_Biol_repl_4,0.47777437477843476,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,0.48257703389030576,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.47515799611157417,,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.4885264932207147,,
HS2024_8_I_N2,0.4841059709254632,,
RB2022_3_RecoveryStrength,0.4778860144979426,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.4770395216088801,,
LY2019_P8+,,,
RB2022_2_RecoveryEndurance,0.47837087653997257,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,0.47693620429909184,,
KS2014_Intensity pY_PV1,0.482539367990224,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.4793503015947597,,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,0.4806064872965001,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,0.4845380689717365,,0.6853367953933855
KBE2022_Log2_Ex_28_U,,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,0.4807356567594671,,
LY2019_P2-,,,
AH2018_LFQ_IT_1_X,0.4775262092977972,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,0.4708763398555432,,0.6819847898141916
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,0.48455735768854685,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,0.4858018783545828,,0.6785310804551353
CK2022_4 40-1,0.48067441548847856,,
SR2019_MCF10A_Biol_repl_4,0.4790604683710993,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,0.48724595252915104,,
HS2024_5_B_T2,0.47786413900183033,,
HS2024_6_I_T1,0.4827682104333519,,
HS2024_5_B_T3,0.4771851682705127,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,,,
AH2018_TMTMS3_3_N,0.48787068897147895,,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,0.48885286684922025,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.48918004841818974,,0.6603846422986454
KBE2022_Log2_Ex_36_T,,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.4730383887030706,,0.6832944064501042
KS2014_Intensity C2,0.47970420288791576,,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,,
CK2022_9 200-1,,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,,,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,0.4777795322431138,,
RBK2021_1332T Late,,,
LY2019_P1-,,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,,
HS2024_3_I_T3,0.4814065917615938,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,0.4753984445931812,,
ZQ2022_C3,0.47774162782541185,,
EJN2021_3_Rest_Ins,0.47999424317644435,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,,
FSO2013_Ratio H/M normalized Rep3___2,0.48683226046698774,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.4810837877065623,,0.6611004693797435
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.4627678317480976,,0.6808237474370002
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,0.47509071544431736,,
KS2014_Intensity N1,0.4805213826387664,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.477525613662801,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,0.4868193845740649,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,0.48165899557527964,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,0.4825070367206449,,
HS2024_5_B_N2,0.4744712139612057,,
HS2024_5_I_N1,0.4745251512928195,,
HS2024_6_I_N1,0.4830092786506646,,
AR2021_KD 48h,0.48606048631517895,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,0.4765443426769355,,
HS2024_5_I_T1,0.4782537450643341,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,0.48095153461687584,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.4696995800999995,,0.6809702179251106
KBE2022_Log2_Ex_29_U,,,
HS2024_7_B_T1,0.47756133400811956,,
AH2018_LFQ_M_2_X,0.47722155567146657,,
AH2018_LFQ_IT_4_N,0.4798074933007406,,
CK2022_15 200-1,,,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,,,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.47667682600590355,,0.6830591183970925
RN2012_H01,0.4802229313070023,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,0.4810464979724011,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.49129092237733446,,0.7152568030071291
HS2024_8_B_T3,0.47111470100910513,,
YA2020_Reporter_intensity_Cancer_No.3,0.47534320367925337,,
KBE2022_Log2_Ex_44_U,,,
WZ2023_Pe_010_20min,0.46861610908073253,,0.6827965532861757
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,0.479143985129966,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,0.48156338120786496,,
FSO2013_Ratio H/M normalized Rep3___1,0.46613859007833125,,
AH2018_SILAC_M_3_C,0.4797679349455849,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,0.48067109912815836,,
AH2018_SILAC_M_2_C,,,
AH2018_SILAC_M_2_X,,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.47540862963725977,,0.6812209856165339
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,0.47569216043846585,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.4743254076723285,,
CK2022_15 16-1,,,
CK2022_3 16-1,,,
LY2019_P4-,,,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,0.4818626889867728,,
HS2024_3_I_N2,0.4721409580504812,,
GF2025_P8_Adh,0.47876513068661997,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.47559762450626925,,
CK2022_10 16-1,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,0.47586083165001575,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.4848940186746886,,0.6726965016123201
EJN2021_2_Ex_Basal,0.480372380300603,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,0.4815104057666949,,
AR2021_L41 10 μM,0.47728063263773457,,
CF2017_EOC 2,0.47129579400937915,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,0.4778108321162527,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,0.4758421926217418,,
RB2022_7_PreSprint,0.4779818269619976,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,0.4770990386376606,,
CK2022_6 16-1,,,
ZX2022_CB treated Replicate 1,0.4720306123926783,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.4756785645157743,,0.6914080562519181
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,0.4735933238354726,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.47433894882235245,,
AR2021_L41 1 μM,0.47283458792488614,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.4757905948942226,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.46624991858252934,,
KS2014_Intensity C4,0.4775141511626887,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,0.4796711103006575,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.4750752385801737,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.476472193524073,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,0.4770787432739554,,
WZ2023_Pu_025_10min,0.46300058853904574,,0.6811063240668468
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,0.4797318173556599,,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,0.48406699124954217,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.46905223327209594,,0.6808781876010451
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,,
KS2014_Intensity C6,0.47729964372946343,,
ZQ2022_N3,0.48600526665564614,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.4809562704283575,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.4724088803700337,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.4803974934667529,,
AH2018_SILAC_IT_2_C,0.47684924954717,,
CK2022_5 40-1,0.4801499081702072,,
AH2018_LFQ_3_X,0.47606354969771375,,
UK2020_UA_3,0.4751892932926207,,
LY2019_P7-,,,
GF2025_P5_Adh,0.4859417108513316,,
RB2022_1_PostStrength,0.48095531516422246,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,0.47170998373648226,,
SR2019_HCC1954_Biol_repl_3,0.4779484540987425,,
CR2017_Ratio Replicate 2.2,0.477202393664943,,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,,
ZQ2022_C1,0.4803422122899943,,
CR2017_Ratio Replicate 2.1,0.47797753566257145,,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,0.4785368888187666,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,0.47925690817689764,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,0.47813412818705964,,
YA2020_Reporter_intensity_Cancer_No.4,0.4785721643953645,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.48110572853320993,,
RB2022_2_PreEndurance,0.4798254277217557,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,,
KS2014_Intensity pY_N1,0.4762959736149363,,
RB2022_1_RecoveryEndurance,0.4738728078434882,,
FSO2013_Ratio H/M normalized Rep1___2,0.4842647154793891,,
HS2024_8_I_T1,0.47753886873414875,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,0.48831869608371126,,0.6673963771172644
AH2018_TMTMS2_1_X,0.4758451162787322,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,0.4784890530626864,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.4804739730728216,,
HS2024_6_I_N2,0.4853312390525652,,
HH2022_Reporter intensity 4,0.4826019212839699,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,0.4842609366237484,,
HS2024_4_I_T3,0.4774047909047671,,
AH2018_SILAC_1_X,0.4775226331216263,,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,0.48468466132402865,,
CF2017_FTE 14,0.4745186442645093,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,,,
EP2017_Untreated R#2 normalized log2 ratio,0.4825549363983991,,0.6739545130867581
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,,
HS2024_5_I_N2,0.47837832450406026,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.4862137164802958,,0.716074651075182
AS2011_Ratio H/L Normalized RNAi_2_1,,,
